You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DRB436

Showing 1 - 12 of 12
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in China (Dabrafenib, Trametinib)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Harbin, Heilongjiang, China
  • +9 more
Jun 13, 2022

BRAF V600 Colorectal Cancer Trial in Worldwide (Dabrafenib, LTT462, Trametinib)

Recruiting
  • BRAF V600 Colorectal Cancer
  • Los Angeles, California
  • +17 more
Jun 7, 2022

Renal Impairment Trial in DeBary, Berlin, Raleigh (dabrafenib)

Completed
  • Renal Impairment
  • DeBary, Florida
  • +2 more
Dec 6, 2020

Hepatic Impairment Trial in United States (dabrafenib)

Terminated
  • Hepatic Impairment
  • Los Angeles, California
  • +3 more
Dec 6, 2020

Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma Trial in Worldwide (dabrafenib, trametinib)

Recruiting
  • Diffuse Astrocytoma
  • +22 more
  • Phoenix, Arizona
  • +26 more
Jan 27, 2023

Cancer Trial in Worldwide (Dabrafenib, Trametinib, Panitumumab)

Completed
Has Results
  • Cancer
  • Scottsdale, Arizona
  • +19 more
Sep 30, 2021

Tumors, Brain Trial in Worldwide (Dabrafenib)

Completed
Has Results
  • Neoplasms, Brain
  • Phoenix, Arizona
  • +25 more
Oct 27, 2021

Cancer Trial in Worldwide (Dabrafenib, Trametinib)

Completed
  • Cancer
  • Little Rock, Arkansas
  • +51 more
Jun 8, 2022

Cancer Trial in Worldwide (Dabrafenib, Trametinib)

Completed
Has Results
  • Cancer
  • Los Angeles, California
  • +49 more
Apr 1, 2022

Melanoma, Adjuvant Trial (Dabrafenib and Trametinib, Dabrafenib, Trametinib)

Available
  • Melanoma
  • Adjuvant
  • Dabrafenib and Trametinib
  • +2 more
  • (no location specified)
Mar 1, 2022

Lymphoblastic Leukemia, Acute Trial in Memphis, Fort Worth (Prednisone, Dexamethasone, Vincristine, Daunorubicin, Doxorubicin,

Completed
Has Results
  • Lymphoblastic Leukemia, Acute
  • Prednisone, Dexamethasone, Vincristine, Daunorubicin
  • +5 more
  • Memphis, Tennessee
  • +1 more
Sep 9, 2020

Melanoma, Metastases Trial in Worldwide (MDX-010 (anti-CTLA4) mAb, MDX-1379 (gp100) Melanoma Peptide Vaccine)

Completed
Has Results
  • Melanoma
  • Metastases
  • MDX-010 (anti-CTLA4) monoclonal antibody
  • MDX-1379 (gp100) Melanoma Peptide Vaccine
  • Tucson, Arizona
  • +208 more
Jun 29, 2011